4AB:ETR
AbbVie Common Stock
€259,50
arrow_upward
+1,13%(+2,90) 1D
20 Nov., 11:02:31 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€260,90
High
€260,90
Low
€258,70
Mkt. cap
501,19 mjd.
Avg. vol.
651,00
Volume
100,00
52-wk high
€272,20
52-wk low
€162,85
No. of employees
57 k
Open
€260,90
High
€260,90
Low
€258,70
Mkt. cap
501,19 mjd.
Avg. vol.
651,00
Volume
100,00
52-wk high
€272,20
52-wk low
€162,85
No. of employees
57 k
News stories
From web sources and news partners
Euronext Markets: Real-time Stock Market Data | live
·
20 uur gelede
AbbVie expands bispecific cancer med push with up to $2.5 billion deal with Germany's Disco
ad-hoc-news.de
·
21 uur gelede
AbbVie stock: Piper Sandler raises target to USD 349
Investing.com
·
1 dag gelede
Abbvie stock price target raised to $349 by Piper Sandler on growth
Puerto Rico Federal Affairs Administration (.gov)
·
2 dae gelede
NEW of PRFAA
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 k
Founded10 Apr. 2012
HeadquartersNorth Chicago, Illinois, Verenigde State van Amerika
SectorHealth Care
Industry-
Websiteabbvie.com